Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins Anne ClavreulAmandine EtcheverryPhilippe Menei Laboratory Investigation 13 December 2014 Pages: 1 - 10
Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells Yusuke S. HoriRyusuke HosodaAtsushi Kuno Laboratory Investigation 21 December 2014 Pages: 11 - 20
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect Georg Karpel-MasslerRichard Eric KastMarc-Eric Halatsch Laboratory Investigation 19 December 2014 Pages: 21 - 33
Phosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model Rong WangWenli ChenYing Mao Laboratory Investigation 19 December 2014 Pages: 35 - 42
High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype Yi PuShouwei LiLihua Sun Laboratory Investigation 20 December 2014 Pages: 43 - 51
Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis Jean-Michel LeméeAnne ClavreulPhilippe Menei Laboratory Investigation 06 January 2015 Pages: 53 - 61
Neuropeptides of the VIP family inhibit glioblastoma cell invasion Stéphanie CochaudAnnie-Claire MeunierCorinne Chadéneau Laboratory Investigation 07 January 2015 Pages: 63 - 73
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells Oula KhouryNoura GhazaleRalph J. Abi-Habib Laboratory Investigation 08 January 2015 Pages: 75 - 85
p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk Valeria BarresiGiovanni BrancaGiovanni Tuccari Laboratory Investigation 07 January 2015 Pages: 87 - 95
HFE polymorphisms affect survival of brain tumor patients Sang Y. LeeBecky Slagle-WebbJames R. Connor Clinical Study 10 December 2014 Pages: 97 - 104
Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases James C. MarshStewart GoldmanJason Fangusaro Clinical Study 11 December 2014 Pages: 105 - 110
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study Manmeet S. AhluwaliaHao XieDavid M. Peereboom Clinical Study 23 December 2014 Pages: 111 - 119
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases Kamran A. AhmedJessica M. FreilichNikhil G. Rao Clinical Study 18 December 2014 Pages: 121 - 126
Examining perceived cancer risk among patients with neurofibromatosis type 1 Elyse R. ParkKelly B. SmithScott R. Plotkin Clinical Study 06 January 2015 Pages: 127 - 133
Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma Douglas E. NeyJulie A. CarlsonChanghu Chen Clinical Study 19 December 2014 Pages: 135 - 143
Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma Victor A. LevinNancy D. MendelssohnDavid M. Chen Clinical Study 11 January 2015 Pages: 145 - 150
Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients Anne-Katrin HickmannMinou Nadji-OhlNikolai J. Hopf Clinical Study 04 January 2015 Pages: 151 - 160
Prospective longitudinal evaluation of emotional and behavioral functioning in pediatric patients with low-grade glioma treated with conformal radiation therapy Victoria W. WillardHeather M. ConklinThomas E. Merchant Clinical Study 09 January 2015 Pages: 161 - 168
Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae David GassMariko DewireTrent R. Hummel Clinical Study 13 January 2015 Pages: 169 - 177
Prognosis of glioblastoma with faint MGMT methylation-specific PCR product Chih-Yi HsuHsiang-Ling HoDonald Ming-Tak Ho Clinical Study 10 January 2015 Pages: 179 - 188
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center Filippo CeccatoGiuseppe LombardiCarla Scaroni Clinical Study 03 January 2015 Pages: 189 - 196
Evaluation of RANO response criteria compared to clinician evaluation in WHO grade III anaplastic astrocytoma: implications for clinical trial reporting and patterns of failure Tomas KazdaJohn G. HardieNadia N. Laack Clinical Study 11 January 2015 Pages: 197 - 203
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients Renata DuchnowskaJacek JassemSunil Badve Clinical Study Open access 06 January 2015 Pages: 205 - 216
Anaplastic oligoastrocytoma: is molecular stratification based on 1p/19q status alone appropriate? Yingjie ZouHarrison Xiao BaiLi Yang Letter to the Editor 03 January 2015 Pages: 217 - 218
